Glutaminyl-peptide cyclotransferase-like protein Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	5-(5-((3,4-Dimethoxyphenylthio)methyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	80.0 [1]
	5-[1-(3-Methoxyphenethyl)-1H-1,2,3-triazole-4-yl]-1H-benzoimidazole	IC50	550.0 [1]
	5-[1-(4-Methoxyphenethyl)-1H-1,2,3-triazole-4-yl]-1H-benzoimidazole	IC50	290.0 [1]
	5-[1-(3,4-Dimethoxyphenethyl)-1H-1,2,3-triazole-4-yl]-1H-benzoimidazole	IC50	470.0 [1]
	5-(1-Phenethyl-1H-1,2,3-triazole-4-yl)-1H-benzoimidazole	IC50	570.0 [1]
	5-(5-(3,4-Dimethoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	400.0 [1]
	5-(5-(2,4-Difluorophenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	830.0 [1]
	2-(3H-Benzimidazol-5-yl)-5-[2-(1,3-benzodioxol-5-yl)ethyl]-1,3,4-thiadiazole	IC50	590.0 [1]
	5-(5-((3,4-Dimethoxyphenylsulfonyl)methyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	410.0 [1]
	5-(5-Phenethyl-1,3,4-thiadiazole-2-yl)-1H-benzoimidazole	IC50	640.0 [1]
	5-(5-(2,3-Dimethoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	360.0 [1]
	Glutaminyl Cyclase Inhibitor 3	IC50	502.0 [1]
	(E)-1-N'-(2,4-Dimethoxyphenyl)-1-N-[3-(5-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	530.0 [1]
	(E)-1-N-[3-(5-Methylimidazol-1-yl)propyl]-2-nitro-1-N'-(3,4,5-trimethoxyphenyl)ethene-1,1-diamine	IC50	620.0 [1]
	(E)-1-N'-(3,4-Dimethoxyphenyl)-1-N-[3-(5-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	730.0 [1]
	(E)-1-N'-Cyclohexyl-1-N-[4-(5-methylimidazol-1-yl)butyl]-2-nitroethene-1,1-diamine	IC50	580.0 [1]
	(E)-1-N'-(1,3-Benzodioxol-5-yl)-1-N-[3-(5-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	340.0 [1]
	(E)-1-N'-(3,4-Dimethoxyphenyl)-1-N-[3-(4-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	8730.0 [1]
	(E)-1-N-[3-(4-Methylimidazol-1-yl)propyl]-2-nitro-1-N'-(3,4,5-trimethoxyphenyl)ethene-1,1-diamine	IC50	9680.0 [1]
	(E)-1-N'-(2,4-Dimethoxyphenyl)-1-N-[3-(4-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	9450.0 [1]
	(E)-1-N'-(1,3-Benzodioxol-5-yl)-1-N-[3-(4-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	10400.0 [1]
	6-[4-[(3-Chloro-4-methoxyphenyl)methyl]-1,2,4-triazol-3-yl]-1H-benzimidazole	IC50	850.0 [1]
	6-[1-(Phenylsulfanylmethyl)triazol-4-yl]-1H-benzimidazole	IC50	570.0 [1]
	5-(5-(3,4,5-Trimethoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	490.0 [1]
	5-(5-(3,4-Difluorophenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	720.0 [1]
	5-(5-(3-Chloro-4-methoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	680.0 [1]
	5-(5-(3-Chloro-4-methoxyphenethyl)-1,3,4-oxadiazol-2-yl)-1H-benzo[d]imidazole	IC50	800.0 [1]
	5-(5-(4-(Methylthio)phenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	760.0 [1]
	5-(4-(2-Chlorobenzyl)-4H-1,2,4-triazol-3-yl)-1H-benzo[d]imidazole	IC50	760.0 [1]
	5-(5-(3-Methoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	450.0 [1]
	2-(3H-Benzimidazol-5-yl)-5-[2-(3-fluorophenyl)ethyl]-1,3,4-thiadiazole	IC50	560.0 [1]
	6-[4-[(4-Phenoxyphenyl)methyl]-1,2,4-triazol-3-yl]-1H-benzimidazole	IC50	480.0 [1]
	5-(4-(4-Methoxybenzyl)-4H-1,2,4-triazol-3-yl)-1H-benzo[d]imidazole	IC50	640.0 [1]
	2-(3H-Benzimidazol-5-yl)-5-[2-(2-chloro-3-methoxyphenyl)ethyl]-1,3,4-thiadiazole	IC50	220.0 [1]
	5-(5-((Phenylthio)methyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	530.0 [1]
	5-(5-(2,5-Dimethoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	480.0 [1]
	5-(5-(2-Methoxyphenethyl)-1,3,4-thiadiazol-2-yl)-1H-benzo[d]imidazole	IC50	760.0 [1]
	(E)-1-N'-(4-Chlorophenyl)-1-N-[3-(4-methylimidazol-1-yl)propyl]-2-nitroethene-1,1-diamine	IC50	8600.0 [1]
	(E)-1-N-[3-(4-Methylimidazol-1-yl)propyl]-1-N'-naphthalen-1-yl-2-nitroethene-1,1-diamine	IC50	7460.0 [1]
	6-[4-[(2,3-Dichlorophenyl)methyl]-1,2,4-triazol-3-yl]-1H-benzimidazole	IC50	520.0 [1]
	N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N'-[3-(4-methylimidazol-1-yl)propyl]-2-nitroethanimidamide	IC50	8790.0 [1]
	N-(1-(3-(5-Methyl-1H-imidazol-1-yl)propylamino)-2-nitrovinyl)cyclohexanamine	IC50	340.0 [1]
	N-(1-(3-(5-Methyl-1H-imidazol-1-yl)propylamino)-2-nitrovinyl)naphthalen-1-amine	IC50	230.0 [1]
	N-(1-(3-(5-Methyl-1H-imidazol-1-yl)propylamino)-2-nitrovinyl)-4-(trifluoromethyl)benzenamine	IC50	430.0 [1]
	N-(4-Chlorophenyl)-N'-[3-(5-methylimidazol-1-yl)propyl]-2-nitroethanimidamide	IC50	320.0 [1]
	N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N'-[3-(5-methylimidazol-1-yl)propyl]-2-nitroethanimidamide	IC50	460.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 46 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Glutaminyl-peptide cyclotransferase-like protein Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 9 May. 2024, https://www.aatbio.com/data-sets/glutaminyl-peptide-cyclotransferase-like-protein-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2024, May 9). Quest Database™ Glutaminyl-peptide cyclotransferase-like protein Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/glutaminyl-peptide-cyclotransferase-like-protein-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan